API Holdings Ltd, the parent of digital healthcare brand PharmEasy, on Monday said it has appointed five independent directors to its board.
“The fresh appointments bring a great amount of cognitive diversity to the board, with luminaries from the world of public service, technology, pharma, medical fraternity, and the consumer sector,” the company said in a statement.
